05/20/2005 - News

Statin use linked to reduced risk of pancreatic and esophageal cancers

By: Susan Aldridge, medical journalist, PhD

Tools:

Statin use linked to reduced risk of pancreatic and esophageal cancers

Reported by Susan Aldridge, PhD, medical journalist

Cholesterol-reducing statin use reduces the risk of pancreatic and esophageal cancer by more than 50 per cent.
We already know that statins reduce cholesterol and help prevent heart attacks and heart disease. Now a team at the University of Illinois reveal that statins may have a role beyond this.

They looked at nearly half a million patients of whom about a third were on statins. There were 475 cases of pancreatic cancer and 659 cases of esophageal cancer. Analysis showed that statin use was linked to a 59 per cent reduction in pancreatic cancer risk and a 56 per cent reduction in esophageal cancer. Both types of cancer tend to have a poor prognosis. If statins can reduce the risk then this could be very useful, although more research is needed before they can be recommended as a preventive measure.

Source
Digestive Disease Week meeting 16th May 2005

Created on: 05/20/2005
Reviewed on: 05/20/2005

No votes yet
Tools: